These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23737478)

  • 1. Elevation of conjunctival epithelial CD45INTCD11b⁺CD16⁺CD14⁻ neutrophils in ocular Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Williams GP; Tomlins PJ; Denniston AK; Southworth HS; Sreekantham S; Curnow SJ; Rauz S
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4578-85. PubMed ID: 23737478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-driven and interleukin-36γ-associated ocular surface inflammation in chronic Stevens-Johnson syndrome.
    Koduri MA; Pingali T; Prasad D; Singh V; Singh S; Shanbhag SS; Basu S; Singh V
    Allergy; 2024 Aug; 79(8):2128-2143. PubMed ID: 38682250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
    Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
    Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multistep Grading System for Evaluation of Chronic Ocular Sequelae in Patients With Stevens-Johnson Syndrome.
    Sharma N; Venugopal R; Maharana PK; Chaniyara M; Agarwal T; Pushker N; Pandey RM; Sangwan S; Sen S; Kashyap S; Sharma A; Khanna N; Vajpayee RB
    Am J Ophthalmol; 2019 Jul; 203():69-77. PubMed ID: 30731084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage.
    Ueta M; Nishigaki H; Sotozono C; Yokoi N; Mizushima K; Naito Y; Kinoshita S
    Sci Rep; 2020 Oct; 10(1):17239. PubMed ID: 33057072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of neutrophil-lymphocyte ratio as a prognostic marker in SJS/TEN patients.
    Rayi MKM; Monteiro RC; Martis J; Bhat RM; Fernandes MS; Jayaraman J; D'souza MJ; Shetty P; Fernandes S
    Arch Dermatol Res; 2024 Aug; 316(8):564. PubMed ID: 39177823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular surface inflammation mediated by innate immunity.
    Ueta M; Kinoshita S
    Eye Contact Lens; 2010 Sep; 36(5):269-81. PubMed ID: 20703156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and Chronic Ophthalmic Involvement, Severity, and Sequelae in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Ganekal S; Nagarajappa A
    Korean J Ophthalmol; 2021 Jun; 35(3):179-187. PubMed ID: 33596622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular surface involvement and histopathologic changes in the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional study.
    Liu Y; Feng J; Ren Y; Shi W; Kang H; Peng Y; Tan Y; Wu R; Zhang G; He Y
    BMC Ophthalmol; 2023 Jul; 23(1):297. PubMed ID: 37400766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of chronic ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Van Zyl L; Carrara H; Lecuona K
    Middle East Afr J Ophthalmol; 2014; 21(4):332-5. PubMed ID: 25371640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Sotozono C; Ueta M; Nakatani E; Kitami A; Watanabe H; Sueki H; Iijima M; Aihara M; Ikezawa Z; Aihara Y; Kano Y; Shiohara T; Tohyama M; Shirakata Y; Kaneda H; Fukushima M; Kinoshita S; Hashimoto K;
    Am J Ophthalmol; 2015 Aug; 160(2):228-237.e2. PubMed ID: 25979679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Wang Q; Lan YP; Qi B; Yin L; Zhang LX; Liu W
    J Dermatol; 2021 Sep; 48(9):1394-1400. PubMed ID: 34060656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
    De Rojas MV; Dart JK; Saw VP
    Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic Mediators in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Saeed HN; Chodosh J
    Semin Ophthalmol; 2016; 31(1-2):85-90. PubMed ID: 26959133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M
    Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of prostaglandin E
    Mieno H; Ueta M; Yamada K; Yamanaka Y; Nakayama T; Watanabe A; Kinoshita S; Sotozono C
    Br J Ophthalmol; 2020 Jul; 104(7):1022-1027. PubMed ID: 31000507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children.
    Catt CJ; Hamilton GM; Fish J; Mireskandari K; Ali A
    Am J Ophthalmol; 2016 Jun; 166():68-75. PubMed ID: 27018234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
    Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.